SELECT DISEASE STATE
NSCLC
Improving Biomarker Testing and Applying Testing Results in Clinical Practice
Overcoming barriers related to biomarker assessment in NSCLC and the application of test results are essential to improving the use of biomarker testing in the practice setting. Slow turnaround times for test results and challenges related to the interpretation of test results remain key barriers to biomarker testing in practice. A unified effort aimed at identifying and addressing these and other challenges related to the testing process is needed to improve clinical utilization of biomarker testing in practice.
Episodes
1Overview of Molecular Targets in Advanced Non–Small Cell Lung Cancer2Overview of Molecular Targets in Advanced Non–Small Cell Lung Cancer3Overview of Molecular Targets in Advanced Non–Small Cell Lung Cancer4Overview of Molecular Targets in Advanced Non–Small Cell Lung Cancer5Overview of Molecular Targets in Advanced Non–Small Cell Lung Cancer6Overview of Molecular Targets in Advanced Non–Small Cell Lung Cancer7Overview of Molecular Targets in Advanced Non–Small Cell Lung Cancer8Overview of Molecular Targets in Advanced Non–Small Cell Lung Cancer9Overview of Molecular Targets in Advanced Non–Small Cell Lung Cancer10Overview of Molecular Targets in Advanced Non–Small Cell Lung Cancer11Overview of Molecular Targets in Advanced Non–Small Cell Lung Cancer12Overview of Molecular Targets in Advanced Non–Small Cell Lung Cancer13Overview of Molecular Targets in Advanced Non–Small Cell Lung Cancer14Overview of Molecular Targets in Advanced Non–Small Cell Lung Cancer15Overview of Molecular Targets in Advanced Non–Small Cell Lung Cancer
© 2023 MJH Life Sciences®. Content developed independently by OncLive®.